Brickell Biotech Statistics Share Statistics Brickell Biotech has 3.01M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 3.01M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 2.98M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 102.89K, so 0% of the outstanding
shares have been sold short.
Short Interest 102.89K Short % of Shares Out n/a Short % of Float 4.18% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.01 and the forward
PE ratio is null.
Brickell Biotech's PEG ratio is
0.
PE Ratio -0.01 Forward PE n/a PS Ratio 1.01 Forward PS n/a PB Ratio 0.02 P/FCF Ratio -0.01 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Brickell Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.15,
with a Debt / Equity ratio of 0.
Current Ratio 6.15 Quick Ratio 6.15 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -571.09
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $25.25K Profits Per Employee $-2.47M Employee Count 16 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax 69K Effective Tax Rate -0.17%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0.08, so Brickell Biotech's
price volatility has been higher than the market average.
Beta 0.08 52-Week Price Change n/a 50-Day Moving Average 2.97 200-Day Moving Average n/a Relative Strength Index (RSI) 37.49 Average Volume (20 Days) n/a
Income Statement In the last 12 months, Brickell Biotech had revenue of 404K
and earned -39.54M
in profits. Earnings per share was -22.16.
Revenue 404K Gross Profit 404K Operating Income -39.41M Net Income -39.54M EBITDA -40.24M EBIT -39.41M Earnings Per Share (EPS) -22.16
Full Income Statement Balance Sheet The company has 26.88M in cash and 69K in
debt, giving a net cash position of 26.82M.
Cash & Cash Equivalents 26.88M Total Debt 69K Net Cash 26.82M Retained Earnings -145.37M Total Assets 18.51M Working Capital 15.38M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -36.15M
and capital expenditures -36K, giving a free cash flow of -36.18M.
Operating Cash Flow -36.15M Capital Expenditures -36K Free Cash Flow -36.18M FCF Per Share -20.27
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -9753.71% and -9787.87%.
Gross Margin 100% Operating Margin -9753.71% Pretax Margin -9770.79% Profit Margin -9787.87% EBITDA Margin -9961.39% EBIT Margin -9753.71% FCF Margin -8956.44%
Dividends & Yields BBI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for BBI.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 5, 2022. It was a
backward
split with a ratio of 1:45.
Last Split Date Jul 5, 2022 Split Type backward Split Ratio 1:45
Scores Altman Z-Score -7.34 Piotroski F-Score 4
